Hernan Martinez, Executive Chairman, commented: '"The second half of 2012 has thus far seen the Company re-focus on its core competencies by selling our BACF investment and signing an MOU for the sale of our Barranquilla port interest.
0x20 Sale of the BACF investment contributed to the $3.
The Biomolecular Analysis Core Facility (BACF
) has been awarded a cash limited grant, issued on the understanding that a company, or companies, will be willing to collaborate with the BACF
and make a contribution towards the equipment and its ongoing maintenance.